**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 63-74-1 |Sulfanilamide | >98 | 200-563-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May cause photosensitive skin reactions
in certain individuals. Not expected to cause an allergic skin
reaction. A single prolonged skin exposure is not likely to result
in the material being absorbed in harmful amounts.
Ingestion:
May cause irritation of the digestive tract. Overexposure may cause
methemoglobinemia.
Inhalation:
May cause respiratory tract irritation. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood. May cause methemoglobinemia.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those
of acute inhalation and ingestion. May cause reproductive and fetal
effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Use water spray, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Store in a cool, dry place. Keep containers tightly closed. Store
protected from light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 63-74-1:
Russia: 1 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: white
Odor: none reported
pH: 5.8-6.1 (0.5%)
Vapor Pressure: Negligible
Viscosity: Not available.
Boiling Point: Not applicable.
Freezing/Melting Point: 163-167 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: 7.5 g/l @ 25C
Specific Gravity/Density: 1.08 g/cm3
Molecular Formula: C6H8N2O2S
Molecular Weight: 172.20
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Light, dust generation, excess heat, prolonged exposure to air.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 63-74-1: WO8400000
LD50/LC50:
CAS# 63-74-1: Oral, mouse: LD50 = 3 gm/kg; Oral, rabbit: LD50 = 1300
mg/kg; Oral, rat: LD50 = 3900 mg/kg.
Carcinogenicity:
Sulfanilamide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 63-74-1: 1
Canada
CAS# 63-74-1 is listed on Canada's DSL List.
CAS# 63-74-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 63-74-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/12/1997 Revision #3 Date: 3/04/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Sulfamic acid
| 5329-14-6 |
|
3-Chlorocinnamic Acid, Predominantly Trans 99+%
| 1866-38-2 |
|
4-(Bromomethyl)-7-Methoxycoumarin 99%
| 35231-44-8 |
|
2-Hydroxy-3-nitropyridine, 98%
| 6332-56-5 |
|
Sulfanilamide
| 63-74-1 |
|
Sulfanilic acid
| 121-57-3 |
|
Nicotine sulfate, 40% aqueous solution
| 65-30-5 |
|
2-Bromobenzaldehyde, 97%
| 6630-33-7 |
|
Bicyclo (3.2.1)Octan-2-One, 90-95%(GC)
| 5019-82-9 |
|
Benzo??b??naphtho??2,3-d??thiophene, 99.5+%
| 243-46-9 |
|
Triethyl Orthoacetate, 99% (GC)
| 78-39-7 |
|
5-Sulfosalicylic acid dihydrate
| 97-05-2 |
|
4-Benzoyloxy-2-Azetidinone, 99%
| 28562-58-5 |
|
Sulfur (Precipitated and Sublimed)
| 7704-34-9 |
|
N-Methyl-Beta-Alaninenitrile, 98%
| 693-02-7 |
|
Trimethyl Orthovalerate
| 13820-09-2 |
|
Ethyl diethoxyphosphinylformate, 98%
| 1474-78-8 |
|
S-Methyl-L-Cysteine, 99+%
| 1187-84-4 |
|
N-Benzoyl-4-Piperidone, 97%
| 24686-78-0 |
|
Succinimide, 99%
| 123-56-8 |
|
Sulfuric acid 90-98%
| 7664-93-9 |
|
Sulfurous Acid
| 7782-99-2 |
|
Silver trifluoromethanesulfonate, 99+%
| 2923-28-6 |
|
Rhodanine-n-acetic acid, 98%
| 5718-83-2 |
|
Tannic Acid
| 1401-55-4 |
|
Diphenic Anhydride, 98%
| 6050-13-1 |
|
4-(Dimethylamino)butyric Acid Hydrochloride, 98%
| 69954-66-1 |
|
(4S,5S)-4,5-Di(aminomethyl)-2,2-dimethyldioxolane, 99+%
| 119322-88-2 |
|
4-Acryloylamidobenzo-18-Crown-6, 98%
| 0-00-1 |
|
2-Thio-6-hydroxypurine hydrate, 98%
| 2487-40-3 |
|
3-Methyl-4-nitrobenzoic acid, 99%
| 3113-71-1 |
|
L-(+)-Tartaric acid
| 87-69-4 |
|
3-Methyl-2-pyrazolin-5-one, 99% (titr.)
| 108-26-9 |
|
2-Nitronaphthalene, tech., 85%
| 581-89-5 |
|
2,6-Dibromopyridine, 98%
| 626-05-1 |
|
5-Methylfurfural, 98+%
| 620-02-0 |
|
Ammonium orthoarsenate trihydrate, 99.999%
| 13477-86-6 |
|
n-Benzylglycine ethyl ester hydrochloride, 98%
| |
|
N-Alpha-Acetyl-L-Lysine-N-Methylamide Monohydrate, 99+%, (TLC)
| 81013-00-5 |
|
(+)-Dimethyl L-Tartrate, 99%
| 608-68-4 |
|
2,5-Dibromotoluene, 99%
| 615-59-8 |
|
2-Aminoperimidine, Hydrobromide Sesquihydrate, 98%
| 40835-96-9 |
|
Nucleic Acid (Pract), 90% (UV-VIS)
| 9008-72-4 |
|
Ethyl 3-Endo-Aminobicyclo[2.2.1]Hept-5-ene -2-Endo-Carboxylate
| 95630-74-3 |
|
Cyclopentanemethanol, 96%
| 3637-61-4 |
|
Tetrahexylammonium Bromide, 99% (Titr.)
| 4328-13-6 |
|
1-(4-Chlorophenyl)-1-cyclohexanecarbonitrile
| |
|
Potassium deuteroxide, 40 wt% solution in d2o, 98+ atom % d
| 24572-01-8 |
|
1-(2-Methoxyphenyl)piperazine, 98+% (GC)
| 35386-24-4 |
|
4-Carboxybenzo-15-Crown-5, 99+%
| 0-00-1 |
|
|